Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant

Journal of Physiology

Volumn 577, Issue 3, 2006, Pages 1053-1065

  Yamada, Satsuki ^a   Kane, Garvan C ^a   Behfar, Atta ^a   Liu, Xiao Ke ^a   Dyer, Roy B ^a   Faustino, Randolph S ^a   Miki, Takashi ^b   Seino, Susumu ^b   Terzic, Andre ^a  

^a Marriott Heart Disease Research Program   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ION; GLIBENCLAMIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MYOCYTE ENHANCER FACTOR 2; POTASSIUM CHANNEL KCNJ11; TRANSCRIPTION FACTOR NFAT; VERAPAMIL; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; EXERCISE TOLERANCE; HEART CATHETERIZATION; HEART DEATH; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE POTENTIAL; HEART PERFORMANCE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; KNOCKOUT MOUSE; LIVER CONGESTION; LUNG CONGESTION; MOLECULAR DYNAMICS; MORTALITY; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SARCOLEMMA; STRESS; UPREGULATION; WILD TYPE; HEART VENTRICLE OVERLOAD; MALE; PROTEIN FUNCTION;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; BLOOD PRESSURE; CONSTRICTION; CYTOPROTECTION; HEART; HEART FAILURE, CONGESTIVE; HOMEOSTASIS; HYPERTENSION; IONS; MICE; MICE, KNOCKOUT; MORTALITY; MYOCARDIUM; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SARCOLEMMA; VENTRICULAR REMODELING;

EID: 33845297629     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.119511     Document Type: Article

References (68)

1. Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B, Dzeja PP, Alekseev AE & Terzic A (2002). Coupling of cell energetics with membrane metabolic sensing: Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem 277, 24427-24434.
2. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP 4th, Boyd AE 3rd, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J & Nelson DA (1995). Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268, 423-426.
3. Ahmad F, Seidman JG & Seidman CE (2005). The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 6, 185-216.
4. + channel channel/enzyme multimer: Metabolic gating in the heart. J Mol Cell Cardiol 38, 895-905.
5. Ashcroft FM (2005). ATP-sensitive potassium channelopathies: Focus on insulin secretion. J Clin Invest 115, 2047-2058.
6. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M & Froguel P (2006). Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355, 456-466.
7. Barki-Harrington L & Rockman HA (2003). Sensing heart stress. Nat Med 9, 19-20.
8. Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M & Terzic A (2005). Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann NY Acad Sci 1049, 189-198.
9. Behfar A & Terzic A (2006). Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med 3, S78-S82.
10. Bienengraeber M, Alekseev AE, Abraham MR, Carrasco AJ, Moreau C, Vivaudou M, Dzeja PP & Terzic A (2000). ATPase activity of the sulfonylurea receptor: A catalytic function for the K ATP channel complex. FASEB J 14, 1943-1952.
11. Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang YP, Alekseev AE & Terzic A (2004). ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic K ATP channel gating. Nat Genet 36, 382-387.
12. Brady PA & Terzic A (1998). The sulfonylurea controversy: More questions from the heart. J Am Coll Cardiol 31, 950-956.
13. Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B & Terzic A (2001). Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci U S A 98, 7623-7628.
14. Chien KR (1999). Stress pathways and heart failure. Cell 98, 555-558.
15. Crabtree GR & Olson EN (2002). NFAT signaling: Choreographing the social lives of cells. Cell 109, S67-S79.
16. Dhar-Chowdhury P, Harrell MD, Han SY, Jankowska D, Parachuru L, Morrissey A, Srivastava S, Liu W, Malester B, Yoshida H & Coetzee WA (2005). The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the K ATP channel macromolecular complex and regulate its function. J Biol Chem 280, 38464-38470.
17. Du Q, Jovanovic S, Clelland A, Sukhodub A, Budas G, Phelan K, Murray-Tait V, Malone L & Jovanovic A (2006). Overexpression of SUR2A generates a cardiac phenotype resistant to ischemia. FASEB J 20, 1131-1141.
18. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A & Lindley KJ (2004). Hyperinsulinism in infancy: From basic science to clinical disease. Physiol Rev 84, 239-275.
19. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL & Terzic A (2002). Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc Natl Acad Sci U S A 99, 10156-10161.
20. + channels. FASEB J 12, 523-529.
21. Frey N & Olson EN (2003). Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol 65, 45-79.
22. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A & Holmes DR Jr (1999). Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33, 119-124.
23. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM & Hattersley AT (2004). Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350, 1838-1849.
24. Gloyn AL, Siddiqui J & Ellard S (2006). Mutations in the genes encoding the pancreatic beta-cell K ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 27, 220-231.
25. Gumina RJ, Pucar D, Bast P, Hodgson DM, Kurtz CE, Dzeja PP, Miki T, Seino S & Terzic A (2003). Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. Am J Physiol Heart Circ Physiol 284, H2106-H2113.
26. Hattersley AT & Ashcroft FM (2005). Activating mutations in Kir6.2 and neonatal diabetes: New clinical syndromes, new scientific insights, and new therapy. Diabetes 54, 2503-2513.
27. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M & Terzic A (2004). Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287, H471-H479.
28. Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, O'Coclain F, Mann DL, Alekseev AE & Terzic A (2003). Cellular remodeling in heart failure disrupts K ATP channel-dependent stress tolerance. EMBO J 22, 1732-1742.
29. Hunter JJ & Chien KR (1999). Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341, 1276-1283.
30. Inagaki N, Gonoi T, Clement JP, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S & Bryan J (1995). Reconstitution of IK ATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270, 1166-1170.
31. + channels. Neuron 16, 1011-1017.
32. Jovanovic S, Du Q, Crawford RM, Budas GR, Stagljar I & Jovanovic A (2005). Glyceraldehyde 3-phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal K ATP channel. EMBO Rep 6, 848-852.
33. Kane GC, Behfar A, Dyer RB, O'Cochlain DF, Liu XK, Hodgson DM, Reyes S, Miki T, Seino S & Terzic A (2006 a). KCNJ11 gene knockout of the Kir6.2 K ATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet 15, 2285-2297.
34. + channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes 53, S169-S175.
35. Kane GC, Lam C-F, O'Cochlain F, Hodgson DM, Reyes S, Liu XK, Miki T, Seino S, Katusic ZS & Terzic A (2006 b). Gene knockout of the KCNJ8 -encoded Kir6.1 K ATP channel imparts fatal susceptibility to endotoxemia. FASEB J 20, 2271-2280.
36. Kane GC, Liu XK, Yamada S, Olson TM & Terzic A (2005). Cardiac K ATP channels in health and disease. J Mol Cell Cardiol 38, 937-943.
37. Lee TM, Lin MS, Tsai CH, Huang CL & Chang NC (2006). Effects of sulfonylureas on left ventricular mass in type 2 diabetic patients. Am J Physiol Heart Circ Physiol (in press).
38. + channel, predisposes to catecholamine-induced ventricular dysrhythmia. Diabetes 53, S165-S168.
39. + channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol 31, 425-434.
40. Luu M, Stevenson WG, Stevenson LW, Baron K & Walden J (1989). Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80, 1675-1680.
41. Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J & Seino S (1998). Defective insulin secretion and enhanced insulin action in K ATP channel-deficient mice. Proc Natl Acad Sci U S A 95, 10402-10406.
42. Miki T & Seino S (2005). Roles of K ATP channels as metabolic sensors in acute metabolic changes. J Mol Cell Cardiol 38, 917-925.
43. Molkentin JD (2004). Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63, 467-475.
44. 2+ in the heart: Contraction versus intracellular signaling. J Clin Invest 116, 623-626.
45. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR & Olson EN (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228.
46. Nichols CG (2006). K ATP channels as molecular sensors of cellular metabolism. Nature 440, 470-476.
47. + channels in cardiac muscle. Nature 305, 147-148.
48. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B & Terzic A (2004). Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet 13, 2505-2518.
49. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Sovik O, Polak M & Hattersley AT (2006). Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355, 467-477.
50. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG & Terzic A (2001). Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem 276, 20566-20571.
51. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT & Ashcroft FM (2004). Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci U S A 101, 17539-17544.
52. Riedel MJ, Steckley DC & Light PE (2005). Current status of the E23K Kir6.2 polymorphism. Hum Genet 116, 133-145.
53. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr & Chien KR (1991). Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A 88, 8277-8281.
54. Saegusa N, Sato T, Saito T, Tamagawa M, Komuro I & Nakaya H (2005). Kir6.2-deficient mice are susceptible to stimulated ANP secretion: K ATP channel acts as a negative feedback mechanism? Cardiovasc Res 67, 60-68.
55. Selivanov VA, Alekseev AE, Hodgson DM, Dzeja PP & Terzic A (2004). Nucleotide-gated K ATP channels integrated with creatine and adenylate kinases: Amplification, tuning and sensing of energetic signals in the compartmentalized cellular environment. Mol Cell Biochem 256 -257, 243-256.
56. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E & Nakaya H (2001). Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res 88, 570-577.
57. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E & Nakaya H (2002). Role of sarcolemmal K ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109, 509-516.
58. + channel-opening drugs. Am J Physiol Cell Physiol 269, C525-C545.
59. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M & Wolf P (2006). Heart Disease and Stroke Statistics -2006 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113, e85-e151.
60. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF & Bryan J (1995). Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268, 426-429.
61. Tong XY, Porter LM, Liu GX, Dhar-Chowdhury P, Srivastava S, Pountney DJ, Yoshida H, Artman M, Fishman GI, Yu C, Iyer R, Morley GE, Gutstein DE & Coetzee WA (2006). Consequences of cardiac myocyte-specific ablation of K ATP channels in transgenic mice expressing dominant negative Kir6 subunits. Am J Physiol Heart Circ Physiol 291, H543-H551.
62. Towbin JA & Bowles NE (2002). The failing heart. Nature 415, 227-233.
63. Van Wagoner DR (1993). Mechanosensitive gating of atrial ATP-sensitive potassium channels. Circ Res 72, 973-983.
64. Wehrens XH, Lehnart SE & Marks AR (2005). Intracellular calcium release and cardiac disease. Annu Rev Physiol 67, 69-98.
65. + conductance. Neuron 31, 233-245.
66. Zingman LV, Hodgson DM, Alekseev AE & Terzic A (2003). Stress without distress: Homeostatic role for K ATP channels. Mol Psychiatry 8, 253-254.
67. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE & Terzic A (2002 a). Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A 99, 13278-13283.
68. + channels. J Biol Chem 277, 14206-14210.